Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Epidemiology of hepatitis E virus infection in a cohort of 4023 immunocompromised patients

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Silent Hypoxia in Patients with SARS CoV-2 Infection before Hospital Discharge

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Prevalence of anti-Hepatitis E virus immunoglobulin G in HIV-infected individuals over three decades

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Hepatitis E virus epidemiology among HIV-infected women in an urban area in Tanzania

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Incidence of HACEK bacteraemia in Denmark: A 6-year population-based study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. High incidence of candidaemia in a nationwide cohort: underlying diseases, risk factors and mortality

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Face masks for the prevention of COVID-19 - Rationale and design of the randomised controlled trial DANMASK-19

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. How to RESPOND to Modern Challenges for People Living with HIV: A Profile for a New Cohort Consortium

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

OBJECTIVES: The prevalence of active, chronic and former hepatitis E virus (HEV) infections in a cohort of immunocompromised patients was investigated, the association with transfusion transmitted (TT) HEV was evaluated, and the HEV seroprevalence was compared with healthy blood donors.

STUDY DESIGN AND METHODS: Serum samples from 4,023 immunocompromised patients at Rigshospitalet, Denmark were retrospectively tested for HEV RNA and anti-HEV IgG. HEV RNA-positive patients were followed up by HEV testing, clinical symptoms and transfusion history. Factors associated with anti-HEV were explored using a multivariable logistic regression analysis. Samples from 1,226 blood donors were retrospectively tested for anti-HEV IgG.

RESULTS: HEV RNA was detected in 6 patients (0.15%) with no indications of chronic HEV infections. HEV RNA prevalence rates among recipients of allogeneic haematopoietic stem cell transplantation (allo-HSCT) and solid organ transplantation (SOT) were 0.58% and 0.21%, respectively. TT-infections were refuted, and transfusion history was not associated with anti-HEV positivity. HEV seroprevalence difference between patients (22.0%) and blood donors (10.9%) waned when adjusting for age and sex (odds ratio 1.20; CI 0.97-1.48).

CONCLUSION: HEV viremia among allo-HSCT and SOT recipients suggests that clinicians should be aware of this diagnosis. No association of blood transfusion with anti-HEV positivity support that food borne transmission is the main transmission route of HEV common to both patients and blood donors.

OriginalsprogEngelsk
TidsskriftInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Vol/bind91
Sider (fra-til)188-195
Antal sider8
ISSN1201-9712
DOI
StatusUdgivet - 2019

Bibliografisk note

Copyright © 2019. Published by Elsevier Ltd.

ID: 58451913